Literature DB >> 26454105

Mild cognitive deficits in patients with primary adrenal insufficiency.

Jitske Tiemensma1, Cornelie D Andela2, Nienke R Biermasz2, Johannes A Romijn3, Alberto M Pereira2.   

Abstract

BACKGROUND: The brain is a major target organ for cortisol considering its high density of glucocorticoid receptors. Several states of hypothalamus-pituitary-adrenal dysregulation point towards impairments in cognitive functioning. However, there is a very limited body of research on the effects of hypocortisolism on cognitive functioning. AIM: To evaluate cognitive functioning in patients with hypocortisolism (i.e., primary adrenal insufficiency (PAI)) and to examine the possible effect of postponing early-morning hydrocortisone intake on cognitive functioning.
METHODS: Thirty-one patients with PAI on regular morning hydrocortisone intake and 31 healthy matched controls underwent nine neuropsychological tests, evaluating memory and executive functioning. In addition, the effect of normal timing and postponement of morning hydrocortisone intake on neuropsychological tests were assessed in an additional 29 patients with PAI.
RESULTS: Compared to controls, patients with PAI performed worse on auditory and visual memory tasks (all P ≤ 0.024) and executive functioning tasks (all P ≤ 0.012). In contrast, patients performed better on a concentration and an attention task (both P<0.05). Postponement of hydrocortisone intake in the morning did not affect the outcomes of neuropsychological tests.
CONCLUSION: Patients on long-term hydrocortisone replacement for PAI show mild cognitive deficits compared to controls. There was no effect of postponement of regular hydrocortisone intake on cognition.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Addison’s disease; Cognitive functioning; Glucocorticoids; Hydrocortisone substitution; Primary adrenal insufficiency

Mesh:

Substances:

Year:  2015        PMID: 26454105     DOI: 10.1016/j.psyneuen.2015.09.029

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  4 in total

1.  Dual-release hydrocortisone and its benefits on cognitive function and quality of sleep.

Authors:  Clarissa Krekeler; Peter Kropp; Antje Katrin Blacha; Amir-Hossein Rahvar; Birgit Harbeck
Journal:  Endocrine       Date:  2021-02-24       Impact factor: 3.633

2.  Salivary cortisol is associated with cognitive changes in patients with fibromyalgia.

Authors:  Yi-Ju Lin; Yu-Chieh Ko; Lok-Hi Chow; Fu-Jung Hsiao; Hung-Yu Liu; Pei-Ning Wang; Wei-Ta Chen
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

Review 3.  Sleep, Cognition and Cortisol in Addison's Disease: A Mechanistic Relationship.

Authors:  Michelle Henry; Kevin Garth Flusk Thomas; Ian Louis Ross
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-27       Impact factor: 5.555

Review 4.  Clinical Unmet Needs in the Treatment of Adrenal Crisis: Importance of the Patient's Perspective.

Authors:  Kim M J A Claessen; Cornelie D Andela; Nienke R Biermasz; Alberto M Pereira
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-20       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.